New DNA Testing May Improve Lung Cancer Treatment

Treatment & Doctors
Reading Time: 2 mins
Publication Date: 04/13/2012
Fact Checked
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Reviewed

Asbestos.com is the nation’s most trusted mesothelioma resource

The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.

Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.

More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.

About The Mesothelioma Center at Asbestos.com

  • Assisting mesothelioma patients and their loved ones since 2006.
  • Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
  • A+ rating from the Better Business Bureau.
  • 5-star reviewed mesothelioma and support organization.
Learn More About Us

Testimonials

"My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family."
Lashawn
Mesothelioma patient’s daughter
  • Google Review Rating
  • BBB Review Rating

How to Cite Asbestos.com’s Article

APA

Hall, M. (2022, March 9). New DNA Testing May Improve Lung Cancer Treatment. Asbestos.com. Retrieved November 29, 2022, from https://www.asbestos.com/news/2012/04/13/new-dna-testing-may-improve-lung-cancer-treatment/

MLA

Hall, Mark. "New DNA Testing May Improve Lung Cancer Treatment." Asbestos.com, 9 Mar 2022, https://www.asbestos.com/news/2012/04/13/new-dna-testing-may-improve-lung-cancer-treatment/.

Chicago

Hall, Mark. "New DNA Testing May Improve Lung Cancer Treatment." Asbestos.com. Last modified March 9, 2022. https://www.asbestos.com/news/2012/04/13/new-dna-testing-may-improve-lung-cancer-treatment/.

Massachusetts-based cancer diagnostics company Foundation Medicine, Inc., announced that a new high-speed DNA scan using the company’s comprehensive cancer genomic test will be made available mid-2012.

The test matches genetic abnormalities insides tumors with drugs that are designed to attack the abnormalities. The result is a treatment plan that can be tailored to the precise mutation in an individual’s DNA, making treatment options more effective and personalized.

Studies show that this type of testing may be especially helpful to patients with lung cancer, a cancer that kills more people in the United States than any other cancer.

Bloomberg reported that the genetic test found mutations in 71 percent of lung cancer tumors that can be attacked with specific cancer drugs that are currently in clinical trials or already on the market.

The DNA scan also has the potential to find a drug that may be effective against one type of cancer even if it was created to fight another.

After Foundation Medicine researchers found a previously unknown genetic flaw in 2 percent of 561 lung cancer tumors, they matched it with Pfizer’s kidney-cancer drug Sutent and AstraZeneca’s thyroid-cancer drug Caprelsa. After being treated with either drug, the abnormal cells died.

Several drug companies including Pfizer and AstraZeneca are taking notice of the new technology. There are hundreds of cancer drugs currently in clinical trials, and Foundation Medicine’s new technology can potentially target individuals who would benefit from a specific drug before the drugs are even on the market.

MIT’s Technology Review reported that Foundation Medicine has been working on this test for over a decade, and recently made strides in developing its product after the cost of DNA decoding dropped substantially and new data on cancer genetics was made available.

The cost to ship tumor samples to Foundation Medicine and have 200 cancer genes sequenced is about $5,000. The cost is predicted to drop as technology becomes more affordable.

Third Rock Ventures and Google Ventures are among the company’s top investors.

Medically Reviewed by Top Mesothelioma Doctors
Free Mesothelioma Guide